Navigation Links
Einstein secures $11 million to continue research on brain aging and Alzheimer's disease
Date:5/9/2011

May 9, 2011 (BRONX, NY) An estimated five million Americans have Alzheimer's disease. Health experts expect the number of cases to rise dramatically as the population ages reaching 13.5 million by 2050. Researchers at Albert Einstein College of Medicine of Yeshiva University are among those investigating the origins and treatments of this disabling disorder.

The Einstein Aging Study (EAS) , which examines both normal brain aging and the special challenges of Alzheimer's disease and other dementias, has recently received a renewal grant of $11 million from the National Institutes of Health's (NIH) National Institute on Aging (NIA) to continue its work. Richard B. Lipton, M.D., the Lotti and Bernard Benson Faculty Scholar in Alzheimer's Disease and professor and vice chair of The Saul R. Korey Department of Neurology, will continue to lead an interdisciplinary team of researchers and health care professionals working to discover dementia's causes and potential therapies.

"We are grateful for the longstanding support of this research program from the NIA and Einstein," said Dr. Lipton, who has been the director of EAS since 1992. "With this new funding, we will continue to explore the relationship between cognitive and motor aging and begin to study the role of pain and stress as well as disease in small blood vessels (microvascular disease) as novel, remediable risk factors for Alzheimer's disease."

Since its initial funding by the NIA 30 years ago, the EAS and its investigators have contributed to the understanding of brain aging by tracking over 2,000 Bronx County residents. Participants who join the EAS must be over 70 years old and meet regularly with researchers, who screen for a variety of physical and mental health indicators and track changes in brain function. Among their findings are that memory decline accelerates seven years before Alzheimer's disease becomes diagnosable. Armed with this knowledge, they are assessing biomarkers, genes and neuro-imaging procedures that will facilitate earlier diagnosis, prevention and treatment of Alzheimer's disease.


'/>"/>

Contact: Kim Newman
sciencenews@einstein.yu.edu
718-430-3101
Albert Einstein College of Medicine
Source:Eurekalert

Related medicine news :

1. NIH awards $10M to Einstein for diabetes research
2. Einstein awarded NIH grant to study drug-resistant TB
3. Einstein scientist awarded $4 million to develop genetic strategy to combat tuberculosis
4. Feinstein Institute to share $5M US Department of Defense grant
5. ALBERT EINSTEIN COLLEGE OF MEDICINE HELPS ADDRESS NEED FOR IMPROVED CANCER CARE IN RURAL AMERICA
6. Einstein-Montefiore researcher will test nanoparticles against pancreatic cancer
7. Susan Band Horwitz, Ph.D., of Einstein, receives lifetime achievement award in cancer research
8. Feinstein scientists identify abnormal disease pathway in dystonia
9. Einstein Montefiore lung specialist to receive award for work with 9/11 rescue workers
10. New York Law Firm Secures $750,000 Settlement for Bronx Man Injured in Slip and Fall Accident
11. Charlie Kimball Secures Partnership with Novo Nordisk, Maker of the Levemir FlexPen, for 2010 Firestone Indy Lights Campaign
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/19/2017)... ... January 19, 2017 , ... Sales Focus Inc. (SFI), ... into the US market. , Over the past 20 years SFI has been recognized ... SFI has launched six new clients into the US market. The new clients ...
(Date:1/19/2017)... ... 2017 , ... Each year, the Southeastern Society of Plastic ... of surgeons from over fifteen different countries come together to share and learn ... to breast reconstruction for breast cancer patients, teaching these surgical techniques which ...
(Date:1/18/2017)... ... ... A recent video posting of a new fidget product gathered online momentum as ... stress and anxiety. No one was more surprised than Think Ink Pen founders ... successful Kickstarter campaign raising $67,000 on the popular crowdfunding platform. “We’ve been in ...
(Date:1/18/2017)... ... 18, 2017 , ... Visually learn facts and tips on ... Certain Dri. , Excessive sweating and hyperhidrosis are common conditions that occur in ... explain the seven types of hyperhidrosis. This visual creates awareness about the condition ...
(Date:1/18/2017)... (PRWEB) , ... January 18, ... ... specialty pharmacy industry’s leading journal and most-read publication among specialty pharmacists and ... Medical Center through its Strategic Alliance Partnership (SAP) program, announced Brian Haug, ...
Breaking Medicine News(10 mins):
(Date:1/19/2017)... , Jan. 18, 2017 The ... Food and Drug Administration (FDA) for its release ... and population health decision makers can proactively share ... products as well as emerging therapies awaiting FDA ... mirrors consensus recommendations that AMCP developed during two ...
(Date:1/18/2017)... 2017  EnteroMedics Inc. (NASDAQ: ETRM ... technology to treat obesity, metabolic diseases and other ... underwritten public offering of units for gross proceeds ... and commissions and offering expenses payable by EnteroMedics. ... A Units, priced at a public offering price ...
(Date:1/18/2017)... PORTLAND, Oregon and PUNE, India ... report published by Allied Market Research, titled, "Breast Imaging Technologies ... projects that the global breast imaging technologies market size was ... reach $4,502 million by 2022, growing at a CAGR of ... and Europe together accounted for ...
Breaking Medicine Technology: